This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biogen Ma Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: George Vandeveer: Innovator in Pharmaceutical Chemistry
Introduction
George Vandeveer is a notable inventor based in Stoneham, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific disorders.
Latest Patents
Vandeveer holds a patent for "Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk." This patent includes compounds of Formula (I') or pharmaceutically acceptable salts thereof, which are designed to treat disorders responsive to the inhibition of Bruton's tyrosine kinase. The patent outlines pharmaceutical compositions comprising these compounds and methods for their application in medical treatments.
Career Highlights
George Vandeveer is currently associated with Biogen MA Inc., a leading biotechnology company. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in treatment methodologies.
Collaborations
Vandeveer collaborates with Brian T. Hopkins, enhancing the research and development efforts within his team. Their combined expertise fosters a productive environment for innovation.
Conclusion
George Vandeveer's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the treatment of various disorders, showcasing the importance of innovation in healthcare.